🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,385

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

74 results for “C4” Clear

  1. A Study to Learn how Various Tablets of the Study Medicine Called Vepdegestrant are Taken up into the Blood in Healthy Adults

    Pfizer Ireland Pharmaceuticals Unlimited Company

    ER+/HER2- Breast Cancer

    phase 1 other active

    1 trial

  2. A Study to Learn if Multiple Doses of the Study Medicine Called Carbamazepine Changes How the Body Processes the Other Study Medicine PF-07248144

    Pfizer Ireland Pharmaceuticals Unlimited Company

    locally advanced or metastatic ER+/HER2- breast cancer

    phase 1 other active

    1 trial

  3. A phase I open-label, multi-center study to evaluate the safety, tolerability, dosimetry, and preliminary activity of [177Lu]Lu-DFC413 and safety and imaging properties of [68Ga]Ga-NNS309 in patients with solid tumors

    Novartis Ophthalmics Europe

    Locally advanced unresectable or metastatic colorectal cancer (CRC), Locally advanced unresectable or metastatic pancreatic ductal adenocarcinoma (PDAC), Locally advanced unresectable or metastatic non-small cell lung cancer (NSCLC), Locally advanced unresectable or metastatic soft tissue sarcoma (excluding GIST and Kaposi sarcoma), Locally advanced unresectable or metastatic HR+/HER2- ductal or lobular breast cancer (BC), Locally advanced unresectable or metastatic triple negative breast cancer (TNBC)

    phase 1 other active

    1 trial

  4. A study to Learn If Study Medicines Called Cyclosporine and Clarithromycin Affect How the Body Processes the Other Study Medicine Called PF-07328948 in Healthy Adults.

    Pfizer Ireland Pharmaceuticals Unlimited Company

    Heart Failure

    phase 1 other active

    1 trial

  5. A study to learn how the study medicine called [14C]PF-07054894 is processed by the body.

    Pfizer Ireland Pharmaceuticals Unlimited Company

    Inflammatory bowel disease.

    phase 1 other active

    1 trial

  6. ADME: A Study to Understand What the Body does to the Study Compound Called PF-07220060 When Taken by Healthy Adults.

    Pfizer Ireland Pharmaceuticals Unlimited Company

    metastatic/advanced breast cancer

    phase 1 other active

    1 trial

  7. ASC47

    China SXT Pharmaceuticals

    Chronic Weight Management

    phase 1 small molecule completed

    1 trial

  8. BG-C477

    Beone Medicines Ireland Limited

    Advanced Solid Tumors

    phase 1 small molecule active

    1 trial

  9. CFT1946

    C4 Therapeutics

    Solid Tumors

    phase 1 small molecule completed

    1 trial

  10. CFT8634

    C4 Therapeutics

    Synovial Sarcoma

    phase 1 small molecule terminated

    1 trial

  11. Cemsidomide

    C4 Therapeutics

    Multiple Myeloma (MM)

    phase 1 small molecule active

    1 trial

  12. GC4419

    Galera Therapeutics

    Renal Impairment

    phase 1 small molecule completed

    1 trial

  13. GC4419

    Galera Therapeutics

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  14. GC4419

    Galera Therapeutics

    Squamous Cell Carcinoma of the Oral Cavity

    phase 1 small molecule completed

    1 trial

  15. GC4419 IV

    Galera Therapeutics

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  16. GC4702 dry powder

    Galera Therapeutics

    Healthy Volunteer

    phase 1 small molecule completed

    1 trial

  17. GC4711 30 mg IV

    Galera Therapeutics

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  18. GC4711 30mg

    Galera Therapeutics

    Healthy

    phase 1 small molecule completed

    1 trial

  19. GC4711 Oral Capsule G-101

    Galera Therapeutics

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  20. HIV-1 C4-V3 Polyvalent Peptide Vaccine

    Praxis Precision Medicines

    HIV Infections

    phase 1 mab completed

    1 trial

  21. LVIVO-TaVec400 product

    China SXT Pharmaceuticals

    Multiple Myeloma (MM)

    phase 1 mab active

    1 trial

  22. LVIVO-TaVec400 product

    Legend Biotech Corp

    Relapsed/Refractory Systemic Lupus Erythematosus (r/r SLE)

    phase 1 mab active

    1 trial

  23. Braftovi 50 mg hard capsules, Zelboraf 240 mg film-coated tablets, Encorafenib, Erbitux 5 mg/mL solution for infusion, PEMBROLIZUMAB, Braftovi 75 mg hard capsules, Braftovi 75 mg hard capsules, Braftovi 50 mg hard capsules, Ribociclib, Ribociclib, NIVOLUMAB, Mektovi 15 mg film-coated tablets, Mektovi 15 mg film-coated tablets, Ribociclib

    Pfizer Ireland Pharmaceuticals Unlimited Company

    Solid tumors

    approved small molecule active

    1 trial

  24. Jakavi 5 mg tablets, Jakavi 10 mg tablets, Jakavi 15 mg tablets, Jakavi 20 mg tablets, Jakavi 5 mg tablets, HDM201, RUXOLITINIB, Jakavi 20 mg tablets, Farydak 15 mg hard capsules, Jakavi 10 mg tablets, Jakavi 15 mg tablets, Jakavi 5 mg tablets, Farydak 10 mg hard capsules, Jakavi 10 mg tablets, Jakavi 15 mg tablets, HDM201, Jakavi 20 mg tablets

    Novartis Ophthalmics Europe

    This study is designed to accept patients with varied disease origins, depending on the parent protocol

    approved small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources